Serum sCD14, polymorphism of CD14-260 and periodontal infection

Oral Diseases

Volumn 15, Issue 7, 2009, Pages 484-489

  Raunio, T ^a,b   Knuuttila, M ^a,c   Karttunen, R ^a,d   Vainio, O ^a,c   Tervonen, T ^a,c  

^a UNIVERSITY OF OULU   (Finland)

^b City of Oulu   (Finland)

^c OULU UNIVERSITY HOSPITAL   (Finland)

^d UNIVERSITY OF HELSINKI   (Finland)

Author keywords

CD14 polymorphism; Periodontal disease; SCD14, serum

Indexed keywords

CD14 ANTIGEN;

ADULT; ANTIGEN DETECTION; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DNA POLYMORPHISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PERIODONTITIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADULT; ANTIGENS, CD14; CASE-CONTROL STUDIES; CHRONIC PERIODONTITIS; FEMALE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; YOUNG ADULT;

EID: 70349146170     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/j.1601-0825.2009.01573.x     Document Type: Article

References (42)

1. Arias MA, Rey Nores JE, Vita N et al (2000). Cutting edge: human B cell function is regulated by interaction with soluble CD14: opposite effects on IgG1 and IgE production. J Immunol 164 : 3480 3485.
2. Armitage GC (1999). Development of a classification system for periodontal diseases and conditions. Ann Periodontol 4 : 1 6.
3. Baldini M, Lohman IC, Halonen M, Erickson R, Holt P, Martinez F (1999). A polymorphism in the 5'flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E. Am J Respir Cell Mol Biol 20 : 976 983.
4. Bas S, Gauthier BR, Spenato U, Stingelin S, Gabay C (2004). CD 14 is an acute-phase protein. J Immunol 172 : 4470 4479.
5. Bazil V, Strominger JL (1991). Shedding as a mechanism of down-modulation of CD14 on stimulated human monocytes. J Immunol 147 : 1567 1574.
6. Bazil V, Horejsi V, Baudys M et al (1986). Biochemical characterization of a soluble form of the 53-kDa monocyte surface antigen. Eur J Immunol 16 : 1583 1589.
7. Duncan L, Yoshioka M, Chandad F, Grenier D (2004). Loss of lipoplysaccharide receptor CD14 from the surface of human macrophage-like cells mediated by Porphyromonas gingivalis outer membrane vesicles. Microb Pathog 36 : 319 325.
8. Garty BZ, Monselise Y, Nitzan M (2000). Soluble CD14 in children with status asthmaticus. Isr Med Assoc J 2 : 104 107.
9. Geerts SO, Nys M, De MP et al (2002). Systemic release of endotoxins induced by gentle mastication: association with periodontitis severity. J Periodontol 73 : 73 78.
10. Giacconi R, Caruso C, Lio D et al (2007). CD 14 C (-260) T polymorphism, atherosclerosis, elderly: role of cytokines and metallothioneins. Int J Cardiol 120 : 45 51.
11. Hayashi J, Masaka T, Ishikawa I (1999). Increased levels of soluble CD14 in sera of periodontitis patients. Infect Immun 67 : 417 420.
12. Hetherington CJ, Kingsley PD, Crocicchio F et al (1999). Characterization of human endotoxin lipoplysaccharide receptor CD14 expression in transgenic mice. J Immunol 162 : 503 509.
13. Hubacek JA, Rothe G, Pit́ha J, Skodova Z, Stanek V, Poledne R (1999). C(-260)→ T polymorphism in the promoter of the CD14 monocyte receptor gene as a risk factor for myocardial infarction. Circulation 99 : 3218 3220.
14. Isaza-Guzmán DM, Aristizábal-Cardona D, Martínez-Pabón MC, Velásquez-Echeverri H, Tobón-Arroyave SI (2008). Estimation of sCD14 levels in saliva obtained from patients with various periodontal conditions. Oral Dis 14 : 450 456.
15. Jin J, Darveau RP (2001). Soluble CD14 levels in gingival crevicular fluid of subjects with untreated adult periodontitis. J Periodontol 72 : 634 640.
16. Kaisho T, Akira S (2001). Dendritic-cell function in Toll-like receptor- and MyD88-knockout mice. Trends Immunol 22 : 78 83.
17. Karhukorpi J, Yan Y, Niemelä S et al (2002). Effects of CD14 promoter polymorphism and H. pylori infection and its clinical outcomes on circulating CD14. Clin Exp Immunol 128 : 326 332.
18. Kitchens RL, Thompson PA (2005). Modylatory effects of sCD14 and LPB on LPS-host cell interactions. J Endotoxin Res 11 : 225 229.
19. Laine ML, Morré SA, Murillo LS, van Winkelhof AJ, Pena AS (2005). CD14 and TLR4 gene polymorphisms in adult periodontitis. J Dent Res 11 : 1042 1046.
20. Landmann R, Zimmerli W, Sansano S et al (1995). Increased circulating soluble CD14 is associated with high mortality in gram-negative septic shock. J Infect Dis 171 : 639 644.
21. LeVan TD, Bloom JW, Bailey TJ et al (2001). A common single nucleotide polymorphism in the CD14 promoter decreases the affinity of Sp protein binding and enhances transcriptional activity. J Immunol 167 : 5838 5844.
22. LeVan TD, Guerra S, Klimecki W et al (2006). The impact of CD14 polymorphisms on the development of soluble CD14 levels during infancy. Genes Immun 7 : 77 80.
23. LeVan TD, Michel O, Dentener M et al (2008). Association between CD14 polymorphisms and serum soluble CD14 levels: effect of atopy and endotoxin inhalation. J Allergy Clin Immunol 121 : 434 440.
24. Lien E, Aukrust P, Sundan A, Müller F, Frøland S, Espevik T (1998). Elevated levels of serum-soluble CD 14 in human immunodeficiency virus type 1 (HIV-1) infection: correlation to disease progression and clinical events. Blood 92 : 2084 2092.
25. Loos BG, John RP, Laine ML (2005). Identification of genetic risk factors for periodontitis and possible mechanisms of action. J Clin Periodontol 32 : 159 179.
26. Martin AC, Laing IA, Khoo SK et al (2006). Acute asthma in children. Relationships among CD14 and CC16 genotypes, plasma levels and severity. Am J Respir Crit Care Med 173 : 617 622.
27. Medzhitov R, Janeway C Jr. (2000). Innate immunity. N Engl J Med 343 : 338 344.
28. Morange PE, Saut N, Alessi MC et al (2005). Interaction between the C-260 T polymorphism of the CD14 gene and the plasma IL-6 concentration on the risk of myocardial infarction: the HIFMECH study. Atherosclerosis 179 : 317 323.
29. Nockher WA, Wick M, Pfister HW (1999). Cerebrospinal fluid levels of soluble CD14 in inflammatory and non-inflammatory diseases of the CNS: upregulation during bacterial infections and viral meningitis. J Neuroimmunol 101 : 161 169.
30. Nunn ME (2003). Understanding the etiology of periodontitis: an overview of periodontal risk factors. Periodontol 2000 32 : 11 23.
31. Pietruska M, Zak J, Pietruski J, Wysocka J (2006). Evaluation of mCD14 expression on monocytes and the blood level of sCD14 in patients with generalized aggressive periodontitis. Adv Med Sci 51 : 166 169.
32. Rey Nores JE, Bensussan A, Vita N et al (1999). Soluble CD14 acts as a negative regulator of human T cell activation and function. Eur J Immunol 29 : 265 276.
33. da Silva Correia J, Soldau K, Christen U, Tobias PS, Ulevitch RJ (2001). Lipopolysaccharide is in close proximity to each of the proteins in its membrane receptor complex: transfer from CD14 to TLR4 and MD-2. J Biol Chem 276 : 21129 21135.
34. Socransky S, Haffajee A (2005). Periodontal microbial ecology. Periodontol 2000 38 : 135 187.
35. Tervonen T, Raunio T, Knuuttila M, Karttunen R (2007). Polymorphisms in CD14 and IL-6 genes associated with periodontal disease. J Clin Periodontol 34 : 377 383.
36. The American Academy of Periodontology (1998). Periodontal disease as a potential risk factor for systemic diseases. J Periodontol 69 : 841 850.
37. Uehara A, Sugawara S, Watanabe K et al (2003). Constitutive expression of a bacterial pattern recognition receptor, CD14, in human salivary glands and secretion as a soluble form in saliva. Clin Diagn Lab Immunol 10 : 286 292.
38. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC (1999). CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249 : 1431 1433.
39. Wüthrich B, Kägi MK, Joller-Jemelka H (1992). Soluble CD14 but not interleukin-6 is a new marker for clinical activity in atopic dermatitis. Arch Dermatol Res 284 : 339 342.
40. Yamazaki K, Ueki-Maruyama K, Oda T et al (2003). Single-nucleotide polymorphism in the CD14 promoter and periodontal disease expression in a Japanese population. J Dent Res 82 : 612 616.
41. Yu S, Nakashima N, Xu BH et al (1998). Pathological significance of elevated soluble CD14 production in rheumatoid arthritis: in the presence of soluble CD14, lipopolysaccharides at low concentrations activate RA synovial fibroblasts. Rheumatol Int 17 : 237 243.
42. Zhao D, Sun T, Zhang X et al (2007). Role of CD14 promoter polymorphisms in Helicobacter pylori infection- related gastric carcinoma. Clin Cancer Res 13 : 2362 2368.